Netherlands – Detection and analysis apparatus – Market consultation for HPV analysis for the cervical cancer screening programme
The purpose of the market consultation is to provide BVO NL with insight into the current possibilities offered by the market for carrying out molecular screening within the Cervical Cancer Screening Programme and into the technological developm
Opportunity description
The purpose of the market consultation is to provide BVO NL with insight into the current possibilities offered by the market for carrying out molecular screening within the Cervical Cancer Screening Programme and into the technological developments expected in this area over the coming years. The market consultation is aimed at obtaining insight into: - the (components of) Total Solutions that market participants can offer for carrying out molecular HPV analysis; - the way in which (components of) these Total Solutions are designed and function; - the performance and quality aspects of these Total Solutions in practice; - the development of molecular diagnostic platforms and the assays that are available or expected to become available on them; - the possibilities for applying new assays and other relevant technological developments during the lifetime of a platform within an existing Total Solution. The information obtained will be used to better understand the possibilities of the market and the expected technological developments and will provide input for the further preparation of project BMHK29. Analysis equipment for the cervical cancer screening programme in the Netherlands. The purpose of the market consultation is to provide BVO NL with insight into the current possibilities offered by the market for carrying out molecular screening within the Cervical Cancer Screening Programme and into the technological developments expected in this area over the coming years. The market consultation is aimed at obtaining insight into: - the (components of) Total Solutions that market participants can offer for carrying out molecular HPV analysis; - the way in which (components of) these Total Solutions are designed and function; - the performance and quality aspects of these Total Solutions in practice; - the development of molecular diagnostic platforms and the assays that are available or expected to become available on them; - the possibilities for applying new assays and other relevant technological developments during the lifetime of a platform within an existing Total Solution. The information obtained will be used to better understand the possibilities of the market and the expected technological developments and will provide input for the further preparation of project BMHK29. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.